La Merie Publishing

La Merie Publishing is an independent business information provider for the biotechnology and pharmaceutical industry. We publish reports, offer R&D database access, and provide consulting in pharmacology and biotechnology.

Market Research Report Titlesort descending Published Pages Price
2013 Sales of Recombinant Therapeutic Antibodies & Proteins Mar 21 2014 37 USD 68.00
2014 Sales of Recombinant Therapeutic Antibodies & Proteins Mar 17 2015 39 USD 140.00
2022 Sales of Recombinant Therapeutic Antibodies, Proteins, Biosimilars & Other Biologics Mar 7 2023 71 USD 528.00
Anti-CD22 Immunotherapeutics in: October 2016 R&D and Business Tracker for Antibody-Drug Conjugates Nov 18 2016 27 USD 225.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates Oct 26 2016 22 USD 225.00
Antibody Report Bundle Mar 18 2014 1400 USD 4,766.00
Antibody Target, Technology & Pipeline Database: 1-Year Subscription Aug 10 2023 40 USD 1,760.00
Antibody Technologies and Attrition Rates – an industry analysis 2013 Mar 18 2013 607 USD 2,960.00
Antibody-Drug Conjugate Pipeline Review by target, drug, phase and company Dec 20 2016 288 USD 880.00
Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis Jan 19 2014 347 USD 2,298.00
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis Nov 30 2015 470 USD 2,500.00
B-Cell Maturation Antigen (BCMA): hot target for emerging treatment modalities Aug 1 2016 39 USD 570.00
BCMA-Targeted Antibodies & T-Cells in: October 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells: Monthly Tracking Reports Nov 18 2016 27 USD 225.00
BCMA-Targeted Immunotherapeutics in: October 2016 R&D and Business Tracker for Bispecific Antibodies Nov 18 2016 21 USD 225.00
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins Mar 22 2018 53 USD 190.00
Botulinum Neurotoxins: A comparative industry analysis of products, pipelines, technologies and stakeholders Jul 17 2014 169 USD 2,125.00
Cadherin 17: A target opportunity to develop effector-enhanced drug modalities May 30 2022 32 USD 450.00
CAR-M Industry Landscape Analysis: Chimeric Antigen Receptor-Macrophage (CAR-M) Stakeholders, Technologies, Pipeline, Partnering and Financing Feb 8 2023 96 USD 2,000.00
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies Oct 26 2016 20 USD 225.00
CD123: a paradigmatic target for immunotherapeutic treatment modalities Aug 1 2016 83 USD 800.00
CD22: A Suitable Antigen for Targeted Payload Delivery by Immunotherapeutics Nov 18 2016 80 USD 784.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells Oct 26 2016 25 USD 225.00
Claudin 18.2 - Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from an Industry Perspective Aug 8 2023 267 USD 2,365.00
Claudin 6, Cadherin 17, ROR1 and GPRC5D-Targeted Therapies: Target Expression Profile, Safety & Efficacy of Drug Modalities, Pipeline Review, and Competitive Landscape Analysis Jul 6 2022 263 USD 2,000.00
Claudin 6: A target opportunity to develop effector-enhanced drug modalities May 30 2022 50 USD 560.00
Competitor Analysis Immunotoxins 2016 Sep 1 2016 31 USD 225.00
Competitor Analysis: Activators of Immune Checkpoints CD40, GITR, OX40, 4-1BB, CD27 & ICOS Nov 18 2016 75 USD 560.00
Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson’s Disease Jan 21 2015 32 USD 249.00
Competitor Analysis: alpha1-Proteinase Inhibitors (alpha1-PI), alpha1-Antitrypsin (AAT) and Elastase Inhibitors Jul 7 2014 32 USD 272.00
Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines Oct 26 2015 44 USD 345.00
Competitor Analysis: Anti-Infective Peptides Nov 7 2014 68 USD 444.00
Competitor Analysis: Anti-Inflammatory Peptides Sep 7 2014 44 USD 317.00
Competitor Analysis: Anti-VEGF and Anti-VEGF-R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis – a 2017 Update Nov 2 2017 58 USD 525.00
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 2014 Mar 11 2014 386 USD 1,514.00
Competitor Analysis: Bispecific Antibodies for Cancer, Inflammatory & Other Diseases Jun 3 2016 180 USD 560.00
Competitor Analysis: Bispecific Antibodies for Immuno-Oncology & Other Diseases Jun 25 2019 121 USD 900.00
Competitor Analysis: Cancer Peptides Nov 12 2014 99 USD 499.00
Competitor Analysis: Cancer Vaccines Mar 25 2014 179 USD 1,112.00
Competitor Analysis: Cardiometabolic Peptides Nov 12 2014 77 USD 499.00
Competitor Analysis: Cardiovascular Peptides Nov 7 2014 59 USD 381.00
Competitor Analysis: CD19-Targeted Therapeutics - 2016 Update Apr 29 2016 74 USD 350.00
Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors Feb 14 2014 67 USD 401.00
Competitor Analysis: CD20 Antibodies 2015 - Biosimilars and Biosuperiors of Rituximab Mar 25 2015 62 USD 346.00
Competitor Analysis: CDK9 and Mcl-1 Inhibitors Mar 22 2018 26 USD 235.00
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics Jan 14 2014 32 USD 267.00
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics 2016 Jun 1 2016 34 USD 225.00
Competitor Analysis: CSF-1R Antagonists for Modulation of the Tumor Microenvironment Dec 8 2016 19 USD 220.00
Competitor Analysis: CXCR4 Antagonists for Modulation of the Tumor Microenvironment Dec 8 2016 20 USD 220.00
Competitor Analysis: Ebola Virus Vaccines and Therapeutics Oct 7 2014 43 USD 254.00
Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux Mar 28 2015 50 USD 288.00

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made market research solution? We can help you with that too.

About Us

At Market Research Reports, Inc. we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer’s needs, be it custom research or syndicated research reports.

Contact Us

Market Research Reports, Inc
16192 Coastal Hwy
Lewes
, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected